InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,304.72
(
0.70%
)
US TECH 100
18,318.00
(
0.95%
)
Dow Jones
39,069.59
(
0.01%
)
Brent Oil
81.97
(
0.00%
)
Bitcoin
68,780.80
(
-0.70%
)
Post# of 251940
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

willyw

Send PM Follow Ignore
Followers 14
Posts 733
Boards Moderated 0
Alias Born 12/09/2013

willyw

Re: DewDiligence post# 238557

Friday, 07/02/2021 11:51:00 AM

Friday, July 02, 2021 11:51:00 AM

Post# of 251940
I'm wondering if I'm following.
There is new data on a new compound (I think) ATI-2173,
which to me looks good (note: Phase 1b results w/ 24 subjects?)
https://www.natap.org/2021/EASL/EASL_45.htm

So then the question would be will the triple therapy be effective?
It looks potentially so to me.
Note that ATI-2173 is different than ABI-H0731 (I believe).

(In 5 days ABUS has only fallen in value since EASL or the collaborative announcement, so it doesn't appear the market is enthused.)

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up